market strategi radar screen smoke
studyoversold rate bullish stock
self-help stori valuat gotten cheap
ignor upgrad outperform
preview el bull case remain intact even grow
note
report provid updat lenabasum pipelin
quarterli updat detail progress across program
analyst certif import disclosur see
follow-up corpor strength off-set netcentr
inxn follow solid quarter trade highest
multipl histori maintain perform
show-m stori cpg headwind maintain
outperform strateg valu pt
 soft mix put focu margin introduc
short interest updat increas industri back half
move sidelin downgrad perform
market strategi radar screen smoke
studyoversold rate bullish stock
self-help stori valuat gotten cheap ignor upgrad outperform
call may seem earli given slow growth trend low street sentiment see good self-help stori rais
rate inst outperform perform establish pt struggl instructur past year
larg tie slowdown domest educ busi uncertainti right medium-term growth
margin profil stock price sinc downgrad report declin time investor
sentiment materi shift away expect unrealist high growth rate mani year futur
street final accept deceler us educ spend trend easili overcom robust growth
intern and/or corpor busi actual hurt instructur think valuat reach attract
level risk/reward attract ignor
preview el bull case remain intact even grow geopolit risk
el report result spent time updat view share ahead print recent data point suggest
continu robust growth china travel retail expect anoth top- bottom-lin beat similar recent quarter
howev expect conserv guid typic el fashion like build cushion geopolit risk reflect
on-going fx headwind share meaning outperform ytd vs gain
less convict share price reaction given meaning out-performance late would take advantag
volatility/profit take el remain top pick us continu close monitor macro/geopolit develop
note
host investor meet teva manag includ kre schultz ceo mike mcclellan cfo kevin mannix
svp ir ran meir vice-president ir discuss cover wide rang topic includ litig debt refinanc
oper improv growth prospect view investor appear comfort manag effort
oper front uncertainti surround opioid price fix litig heritag issu remain top
mind manag indic litig typic take sever year resolv win perspect run
good sustain busi strong revenu earn growth creat sharehold valu feel confid team
remain focus improv margin secur cash flow sustain top-lin continu manag legal
follow result updat model reflect quarterli financi price target remain unchang
report sale ahead our/consensu estim grew y/i
ex-purapli led stronger expect sale purapli surgic sport medicin sm oper loss
quarter lower think sale beat slightli lower sg awc primarili driven addit sale hire
purapli continu adopt amniot product ss growth led amniot product nucel nushield
sale forc expans sale guidanc rais higher expect sale contribut
across purapli sm manag note pull-through non-purapli product purapli strong adopt
caught mot follow earn discuss progress key develop net loss better
expect vs estim follow june approv mot second-gener pure-vu system
posit reduc data compani recent financ focu launch pure-vu hospit set first
site expect util pure-vu mot final stage scale commerci product activ
engag healthcar system prepar us launch near-term mileston includ expans sale reps/
clinic specialist key us locat expans market program engag hospitals/physician fill ce mark
target pure-vu europ
report net loss vs estim given ev despit sever prophylact
therapeut vaccin candid activ develop well differenti technolog platform see share
oversold current level
report provid updat lenabasum pipelin platform
kaken up-front allow post net incom see result agonist
lenabasum late-stag clinic program system sclerosi cystic fibrosi dermatomyos well phase
trial lupu invers agonist posit develop nash enter clinic later year sever
key leadership hire market med affair suppli chain made begin earli commerci prep
market research /kol engag initi anticip opportun ssc cf begun continu explor
potenti asian partnership beyond japan view risk/reward lenabasum clinic program attract reiter
outperform
report net loss vs estim compani reiter anticip time sever
catalyst relat tazemetostat pipelin includ fl nda submiss expect share outperform
tazemetostat progress develop approach commerci earlier pipelin advanc
quarterli updat detail progress across program
report result along busi updat outlin pipelin progress transform pipelin
small molecul develop gene therapi platform recent day focus develop
axo-lenti-pd parkinson diseas pd gangliosidosi tay-sach
sandhoff diseas encourag recent progress includ follow data first cohort
sunrise-pd studi axo-lenti-pd initi safety/toler data tay-sach dose patient
data first dose gangliosidosi patient initi data expect
balanc updat model reflect actual
cloud
follow-up corpor strength off-set netcentr weak growth solid
top line continu pressur netcentr y/i growth like continu partial off-set strong
corpor growth believ strength corpor sustain busi look low-cost secur
reliabl internet provid bandwidth requir increas cloud adopt neg less optimist
netcentr although new direct-to-consum video offer launch later year help volum price remain
pressur manag reiter long-term guidanc consolid revenu growth annual adj ebitda margin
expans bp see bp reason stock high end histor trade rang
maintain perform rate
cloud
inxn follow solid quarter trade highest multipl histori maintain perform
organ revenu grew y/i line exclud non-recur revenu lumpi higher due
instal activ believ fundament demand remain strong cloud provid focus key tier market
macro/brexit risk inxn good line-of-sight futur demand invest heavili footprint inxn
expans total squar meter schedul open ye would like see better arpu growth expect
build slow risk includ high leverag neg currenc slightli midpoint
guidanc stock trade ebitda versu five-year averag like due neg govern bond
yield europ
show-m stori cpg headwind maintain outperform strateg valu pt
reduc pt follow manag reduc revenue/ebitda
lower spend three cpg custom delay target check-out faster declin specialti
retail concern difficulti forecast cpg industri advertis budget compani see lower
market across industri indic limit visibl larg client spend stabil addit expect investor
skeptic competit larger impact macro posit side media revenu acceler
solid retail perform expand influenc market stock clearli show-m camp maintain
outperform rate data scale advantag uniqu offer larg retail provid underli strateg valu
samsung narrow global chip market lead say ih digitim
goe soft symantec bid ee time
discontinu research coverag endur intern group previous perform rate due realloc
analyst resourc figur report up-to-d last comment februari
week continent announc increas focu electrif powertrain divis indic would
enter batteri manufactur busi due cost perform disadvantag addit automot
futur powertrain survey result made public indic industri particip look hybrid reach market
share bev reach believ industri insid import perspect note tsla
present technolog confer week highlight critic issu face automak provid compel
ev product advantag cost contend model base price compar vehicl lead market
share gain believ continu walk cost curv learn signific mistak previou
factori design potenti creat scale cost advantag vs competitor remain slow bring ev
market
sustain growth resourc optim
 soft mix put focu margin introduc estim
report result consensu mix/oper ineffici exacerb slowdown north america
oil ga spend manag anticip improv least prudent view
reconfigur stress suppli chain move past new product/labor ramp cost clear prioriti subsequ
quarter veth acquisit continu mitig headwind marin end-market increas percentag
sale mix call commentari indic appetit inorgan diversif reduc gm /ep
estim introduc estim maintain price target
short interest updat increas industri back half juli
close friday short interest data secur sever major exchang releas juli note
increas aggreg short interest compani coverag increas across broader univers
 ps track back half juli summar data herein short interest chang coverag univers
page short interest chang broad univers page graphic repres chang short interest
coverag compani pp data report twice month typic delay
move sidelin downgrad perform
knew stellu dividend coverag would tight coupl quarter core net invest incom nii
even littl lighter expect combin new non-accru lead us downgrad stock
perform outperform remov price target share trade right around group
stock expens risk profil increas greater bargain
think good chanc scm work way current challeng monitor stock futur
opportun time move sidelin
report gaap ep vs estim consensu exclud impair
tremont mortgag trust unreal loss travelcent also includ estim
estim core ep compar core estim henc would character quarter
larg line hpt track close net spirit mta reit portfolio end septemb
increas annual manag servic revenu compani continu strong balanc sheet
cash debt end quarter
